A patient with diabetes and recent NSTEMI treated with stent, clopidogrel, and atorvastatin ~2 months ago is transferred from OSH with ALT 1500, bilirubin 15 The leading diagnosis is statin liver injury But that's not what it is. Not at all 🧵 #livertwitter #liverstory

👍🏻👍🏻NEJM #mybodymychoice

ICYMI: A new staging classification of primary #vhdMR based on extra-mitral valve cardiac involvement, including severe LA dilatation & RV dysfunction, showed independent prognostic value. bit.ly/3x8gzPW #JACCIMG #EchoFirst #cvImaging

Lucky Friday 🍀

M-TEER for atrial functional #mitralvalve regurgitation (FMR)? Atrial FMR is a frequent cause of FMR & can be effectively treated w/ #MTEER. Check out the new results from EuroSMR registry: bit.ly/3oI9Us3 #JACCIMG #cvImaging #MitraClip #CardioTwitter #echofirst #vhdMR

Atrial FMR is a frequent cause of FMR and can be effectively treated with TEER to improve symptoms at follow-up. Transcatheter Mitral Valve Repair in Patients With Atrial Functional Mitral Regurgitation pubmed.ncbi.nlm.nih.gov/35842361/

Want to know the outcomes of MitraClip in secondary MR since FDA approval? Come join me at #ESC2022 where I will be presenting the COAPT Post Approval Study as a Late-Breaker on Aug 28 Paul Mahoney Pradeep Yadav Wayne Batchelor, MD Jason Rogers Barker European Society of Cardiology Journals

Happy to share our new publication European Society of Cardiology Journals with Lukas Stolz on RV-Dysfunction in pts. treated with #MTEER for primary MR. 💥AG jörg hausleiter 🔗 doi.org/10.1002/ejhf.2… #RVCoupling #PMR Daniel Kalbacher Sebastian Ludwig Benedikt Koell Philipp Lurz Univ.-Prof. Dr. Ralph Stephan von Bardeleben Nicole Karam, MD, PhD, FESC

Cath lab personal before starting elective PCI receiving results of the REVIVED-BCIS2 trial

Great to see our work published European Society of Cardiology Journals! ➡️RVD in pts. with primary MR treated with #MTEER. 🔗 pubmed.ncbi.nlm.nih.gov/36054557/ Lukas Stolz Daniel Kalbacher Benedikt Koell Sebastian Ludwig Ludwig T Weckbach Mathias Orban Nicole Karam, MD, PhD, FESC Univ.-Prof. Dr. Ralph Stephan von Bardeleben Philipp Lurz ChristosIliadis jörg hausleiter

Interesting new score for risk stratification prior to TEER. #COAPTScore JACC Journals jacc.org/doi/10.1016/j.…

Transcatheter tricuspid valve replacement is emerging as a therapeutic option amongst patients with secondary tricuspid regurgitation. This systematic review and meta-analysis provides an overview of the early and late outcomes after isolated surgical TVR. ow.ly/c1jN50L1I5O

Please save the date: ❤️2. HAMBURG INTERVENTIONS 🗓️10.12.2022 🎄Empire Riverside Hotel Hamburg + online Update interventionelle Kardiologie: Innovative Techniken, aktuelle Studien & spannende Heart Team Diskussionen. Wir freuen uns auf Sie! Anmeldung: hamburg-interventions.de

#PRIMEMR Benedikt Koell Sebastian Ludwig Andrea Scotti Augustin Coisne Daniel Kalbacher

🗞️ The EXPAND study is now out on #EJHF European Society of Cardiology Journals In our Editorial: 🎯#MitraClip NTR vs. XTR 🎯1y results w/ MitraClip 3rd gen 🎯how to reduce leaflet injury & SLDA 🌐Editorial: onlinelibrary.wiley.com/doi/10.1002/ej… 🌐Article: onlinelibrary.wiley.com/doi/full/10.10… Azeem Latib #CardioED #MedEd #TEER

Our latest study on #TMVR or #TEER for secondary MR has just been published in European Society of Cardiology Journals. Great collaborative effort by the CHOICE-MI and EuroSMR investigators! Daniel Kalbacher Lenard Conradi thomas modine Juan F. Granada Augustin Coisne jörg hausleiter onlinelibrary.wiley.com/doi/epdf/10.10…

#LateBreakingClinicalTrials: In seinem Vortrag bei der #DGKJahrestagung präsentiert Prof. B. Köll das PRIME-MR Register.

A cautionary tale about the transient dysfunction of a leadless pacemaker system after cardioversion - Be ready to pace! Just published online in Heart Rhythm Case Reports Julius Nikorowitsch heartrhythmcasereports.com/article/S2214-…

Check out this new #CJC #Editorial which: highlights the challenges of the TMVR screening process & provides a Glimpse into the Future Technological Needs and Requirements 👉 onlinecjc.ca/article/S0828-…

Patients with severe MR undergoing TMVR (N=400) from the CHOICE-MI registry: 🔝 MR elimination 🔝 Symptomatic improvement 1y ☠️ 27.9% 2y ☠️ 38.1% 30-day determinants of mortality: - LVOT obstruction 🚫 - Access site/Bleeding 🩸 thomas modine Lenard Conradi Juan F. Granada